Orchid Pharma Limited
Orchid Pharma Limited (ORCHPHARMA) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
orchidpharma.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Stock price
₹934.65
Market cap
5,581 Cr
Stock P/E
3139.6
P/B
3.68
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 199 Cr | 221 Cr | 217 Cr | 244 Cr | 223 Cr | 217 Cr | 237 Cr | 173 Cr | 194 Cr | 207 Cr | 238 Cr | 304 Cr |
| Operating expenses (approx.) | 175 Cr | 185 Cr | 188 Cr | 212 Cr | 192 Cr | 191 Cr | 209 Cr | 159 Cr | 195 Cr | 206 Cr | 211 Cr | 290 Cr |
| EBITDA | 23 Cr | 35 Cr | 29 Cr | 32 Cr | 30 Cr | 26 Cr | 28 Cr | 14 Cr | -1 Cr | 2 Cr | 27 Cr | 14 Cr |
| OPM % | 11.7% | 16.0% | 13.3% | 13.3% | 13.6% | 12.1% | 11.8% | 8.2% | -0.8% | 0.8% | 11.3% | 4.6% |
| Other income | 8 Cr | 8 Cr | 13 Cr | 8 Cr | 8 Cr | 8 Cr | 4 Cr | 11 Cr | 11 Cr | 6 Cr | 7 Cr | 2 Cr |
| Interest | 4 Cr | 4 Cr | 3 Cr | 3 Cr | 3 Cr | 4 Cr | 4 Cr | 3 Cr | 4 Cr | 3 Cr | 3 Cr | 2 Cr |
| Depreciation | 8 Cr | 9 Cr | 8 Cr | 8 Cr | 9 Cr | 9 Cr | 9 Cr | 9 Cr | 9 Cr | 9 Cr | 9 Cr | 11 Cr |
| Profit before tax | 20 Cr | 29 Cr | 30 Cr | 29 Cr | 27 Cr | 21 Cr | 22 Cr | 15 Cr | -6 Cr | -13 Cr | 24 Cr | 3 Cr |
| Tax % | 0.0% | 0.0% | -10.5% | -0.5% | 0.0% | 0.0% | -0.2% | 0.0% | 0.0% | 0.0% | 0.0% | 2.2% |
| Net profit | 20 Cr | 29 Cr | 33 Cr | 29 Cr | 27 Cr | 21 Cr | 22 Cr | 15 Cr | -6 Cr | -13 Cr | 24 Cr | 3 Cr |
| EPS (₹) | ₹4.30 | ₹6.18 | ₹6.81 | ₹5.79 | ₹5.37 | ₹4.10 | ₹4.40 | ₹2.94 | ₹-1.13 | ₹-2.49 | ₹4.69 | ₹0.54 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 688 Cr | 600 Cr | 508 Cr | 450 Cr | 560 Cr | 666 Cr | 819 Cr | 922 Cr | 811 Cr | Sign in for TTM |
| Operating expenses (approx.) | 672 Cr | 618 Cr | 534 Cr | 400 Cr | 510 Cr | 582 Cr | 709 Cr | 805 Cr | 770 Cr | Sign in for TTM |
| EBITDA | 16 Cr | -18 Cr | -25 Cr | 50 Cr | 50 Cr | 84 Cr | 111 Cr | 117 Cr | 41 Cr | Sign in for TTM |
| OPM % | 2.3% | -3.0% | -5.0% | 11.1% | 8.9% | 12.6% | 13.5% | 12.7% | 5.1% | Sign in for TTM |
| Other income | 20 Cr | 17 Cr | 24 Cr | 15 Cr | 9 Cr | 19 Cr | 31 Cr | 27 Cr | 35 Cr | Sign in for TTM |
| Interest | 302 Cr | 0.30 Cr | 4 Cr | 51 Cr | 32 Cr | 32 Cr | 16 Cr | 15 Cr | 13 Cr | Sign in for TTM |
| Depreciation | 133 Cr | 130 Cr | 126 Cr | 109 Cr | 87 Cr | 55 Cr | 33 Cr | 35 Cr | 35 Cr | Sign in for TTM |
| Profit before tax | -399 Cr | 69 Cr | -131 Cr | -117 Cr | -2 Cr | 46 Cr | 89 Cr | 99 Cr | 20 Cr | Sign in for TTM |
| Tax % | 11.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -3.5% | -0.2% | -0.9% | Sign in for TTM |
| Net profit | -353 Cr | 69 Cr | -131 Cr | -117 Cr | -2 Cr | 46 Cr | 92 Cr | 100 Cr | 21 Cr | Sign in for TTM |
| EPS (₹) | ₹-39.65 | ₹7.80 | ₹-32.11 | ₹-28.55 | ₹-0.48 | ₹11.35 | ₹19.06 | ₹19.65 | ₹4.05 | Sign in for TTM |
| Dividend payout % | — | — | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 89 Cr | 89 Cr | 41 Cr | 41 Cr | 41 Cr | 41 Cr | 51 Cr | 51 Cr | 51 Cr |
| Reserves | -881 Cr | -793 Cr | 984 Cr | 612 Cr | 607 Cr | 648 Cr | 1,119 Cr | 1,217 Cr | 1,237 Cr |
| Borrowings | 2,588 Cr | 2,120 Cr | 501 Cr | 430 Cr | 268 Cr | 331 Cr | 134 Cr | 174 Cr | 357 Cr |
| Other liabilities | 1,329 Cr | 1,661 Cr | 196 Cr | 154 Cr | 195 Cr | 205 Cr | 250 Cr | 246 Cr | 266 Cr |
| Total liabilities | 3,125 Cr | 3,077 Cr | 1,722 Cr | 1,237 Cr | 1,111 Cr | 1,225 Cr | 1,554 Cr | 1,688 Cr | 1,911 Cr |
| Fixed assets (net) | 1,268 Cr | 1,141 Cr | 1,021 Cr | 670 Cr | 583 Cr | 573 Cr | 619 Cr | 632 Cr | 613 Cr |
| CWIP | 257 Cr | 264 Cr | 78 Cr | 7 Cr | 10 Cr | 46 Cr | 16 Cr | 64 Cr | 341 Cr |
| Investments | 1 Cr | 0.47 Cr | 0.34 Cr | 15 Cr | 45 Cr | 44 Cr | 46 Cr | 50 Cr | 53 Cr |
| Inventories | 194 Cr | 170 Cr | 156 Cr | 153 Cr | 173 Cr | 229 Cr | 264 Cr | 326 Cr | 256 Cr |
| Trade receivables | 120 Cr | 120 Cr | 68 Cr | 136 Cr | 171 Cr | 215 Cr | 196 Cr | 242 Cr | 264 Cr |
| Cash & bank | 35 Cr | 92 Cr | 90 Cr | 16 Cr | 4 Cr | 23 Cr | 4 Cr | 21 Cr | 7 Cr |
| Other assets | 1,250 Cr | 1,290 Cr | 309 Cr | 240 Cr | 124 Cr | 95 Cr | 409 Cr | 353 Cr | 377 Cr |
| Total assets | 3,125 Cr | 3,077 Cr | 1,722 Cr | 1,237 Cr | 1,111 Cr | 1,225 Cr | 1,554 Cr | 1,688 Cr | 1,911 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | — | 89 Cr | 19 Cr | 126 Cr | 19 Cr | 101 Cr |
| Cash from investing | — | — | — | — | 116 Cr | -31 Cr | -312 Cr | -27 Cr | -285 Cr |
| Cash from financing | — | — | — | — | -217 Cr | 31 Cr | 167 Cr | 25 Cr | 170 Cr |
| Net cash flow | — | — | — | — | -11 Cr | 18 Cr | -19 Cr | 18 Cr | -14 Cr |
| Free cash flow (OCF − Capex) | — | — | — | — | 75 Cr | -66 Cr | 126 Cr | -131 Cr | -282 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| ROCE % | -6.5% | -10.5% | -8.3% | -6.0% | 4.6% | 7.7% | 8.1% | 7.9% | 2.0% |
| ROE % | — | — | -12.8% | -17.8% | 0.0% | 0.0% | 7.9% | 7.9% | 1.6% |
| Debtor days | 63 | 73 | 49 | 110 | 111 | 118 | 87 | 95 | 118 |
| Inventory days | 207 | 235 | 241 | 227 | 185 | 205 | 183 | 203 | 202 |
| Days payable | 383 | 419 | 160 | 163 | 179 | 163 | 159 | 138 | 181 |
| Cash conversion cycle | -113 | -111 | 130 | 173 | 116 | 160 | 111 | 160 | 139 |
| Debt / equity | 0.00 | 0.00 | 0.49 | 0.66 | 0.41 | 0.48 | 0.11 | 0.14 | 0.28 |
| Current ratio | 0.34 | 0.30 | 3.25 | 3.02 | 1.81 | 1.35 | 3.04 | 2.83 | 2.45 |
| Net debt / EBITDA | 162.67 | — | — | 0.00 | 0.00 | 3.69 | 1.18 | 1.31 | 8.52 |
Compare with peers
Loading peers…